Literature DB >> 21831152

Change in mortality risk over time in young kidney transplant recipients.

B J Foster1, M Dahhou, X Zhang, R W Platt, J A Hanley.   

Abstract

Mortality risk for kidney transplant recipients may change with increasing accumulated exposure to the "transplantation milieu." We sought to characterize changes over time in mortality rate and in age-, sex- and race-standardized mortality ratios (SMR) relative to the general population, and to estimate the association between increasing time since first transplant and mortality risk. A total of 18 911 patients who received a first transplant at <21 years old (1983-2006), and whose data were recorded in the USRDS, were studied. There were 2713 deaths over a median follow-up of 8.9 (interquartile range 4.0-14.5; maximum 23) years. Among those with graft function, mortality was highest in the first post transplant year; beyond the first year of the first transplant, age-adjusted mortality rates and SMRs decreased slightly over follow-up. Cause of death was cardiovascular for 34.6%, infection for 19.5%, malignancy for 5.8%, other for 21.4% and unknown for 18.7%. For every 1-year time increment after the end of the first post transplant year, age-adjusted all-cause and cardiovascular mortality rates fell by 1% (p = 0.06) and 16% (p = 0.007), respectively; infection-related mortality rate did not change over time (p = 0.5). These results suggest that exposure to the transplantation milieu has no cumulative negative effects on cardiovascular health over the long term. ©2011 The Authors Journal compilation
© 2011 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Mesh:

Year:  2011        PMID: 21831152     DOI: 10.1111/j.1600-6143.2011.03691.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  26 in total

1.  Cardiovascular Disease Risk Factors and Left Ventricular Hypertrophy in Girls and Boys With CKD.

Authors:  Rebecca L Ruebner; Derek Ng; Mark Mitsnefes; Bethany J Foster; Kevin Meyers; Bradley Warady; Susan L Furth
Journal:  Clin J Am Soc Nephrol       Date:  2016-09-14       Impact factor: 8.237

2.  End-stage kidney disease after pediatric nonrenal solid organ transplantation.

Authors:  Rebecca L Ruebner; Peter P Reese; Michelle R Denburg; Peter L Abt; Susan L Furth
Journal:  Pediatrics       Date:  2013-10-14       Impact factor: 7.124

3.  Survival after Kidney Transplantation during Childhood and Adolescence.

Authors:  Anna Francis; David W Johnson; Anette Melk; Bethany J Foster; Katrina Blazek; Jonathan C Craig; Germaine Wong
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-19       Impact factor: 8.237

Review 4.  Cardiovascular disease in children with chronic kidney disease.

Authors:  Mark M Mitsnefes
Journal:  J Am Soc Nephrol       Date:  2012-03-01       Impact factor: 10.121

5.  Factors associated with cardiovascular target organ damage in children after renal transplantation.

Authors:  Bianca Borchert-Mörlins; Daniela Thurn; Bernhard M W Schmidt; Anja K Büscher; Jun Oh; Tanja Kier; Elena Bauer; Sabrina Baig; Nele Kanzelmeyer; Markus J Kemper; Rainer Büscher; Anette Melk
Journal:  Pediatr Nephrol       Date:  2017-08-13       Impact factor: 3.714

6.  Treatments and outcomes for end-stage renal disease following Wilms tumor.

Authors:  Yevgeny Grigoriev; Jane Lange; Susan M Peterson; Janice R Takashima; Michael L Ritchey; Dicken Ko; James H Feusner; Robert C Shamberger; Daniel M Green; Norman E Breslow
Journal:  Pediatr Nephrol       Date:  2012-03-20       Impact factor: 3.714

7.  The impact of socioeconomic status and geographic remoteness on access to pre-emptive kidney transplantation and transplant outcomes among children.

Authors:  Anna Francis; Madeleine Didsbury; Wai H Lim; Siah Kim; Sarah White; Jonathan C Craig; Germaine Wong
Journal:  Pediatr Nephrol       Date:  2015-12-21       Impact factor: 3.714

8.  Short, frequent, 5-days-per-week, in-center hemodialysis versus 3-days-per week treatment: a randomized crossover pilot trial through the Midwest Pediatric Nephrology Consortium.

Authors:  Benjamin L Laskin; Guixia Huang; Eileen King; Denis F Geary; Christoph Licht; Joshua P Metlay; Susan L Furth; Tom Kimball; Mark Mitsnefes
Journal:  Pediatr Nephrol       Date:  2017-04-08       Impact factor: 3.714

Review 9.  Long-term effects of paediatric kidney transplantation.

Authors:  Christer Holmberg; Hannu Jalanko
Journal:  Nat Rev Nephrol       Date:  2015-12-14       Impact factor: 28.314

10.  Changes in Excess Mortality from End Stage Renal Disease in the United States from 1995 to 2013.

Authors:  Bethany J Foster; Mark M Mitsnefes; Mourad Dahhou; Xun Zhang; Benjamin L Laskin
Journal:  Clin J Am Soc Nephrol       Date:  2017-12-14       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.